Nalaganje...
Antibody Drug Conjugates: Preclinical Considerations
The development path for antibody drug conjugates (ADCs) is more complex and challenging than for unmodified antibodies. While many of the preclinical considerations for both unmodified and antibody drug conjugates are shared, special considerations must be taken into account when developing an ADC....
Shranjeno v:
| izdano v: | AAPS J |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406963/ https://ncbi.nlm.nih.gov/pubmed/25724883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-015-9738-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|